HemoSonics Quantra System Cleared by FDA for Obstetric Bleeding
Durham, N.C., September 25, 2025 – HemoSonics LLC, a medical device innovator in acute bleeding management, has received 510(k)...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Medical Devices, Diagnostics, Radiation-Emitting Products
Durham, N.C., September 25, 2025 – HemoSonics LLC, a medical device innovator in acute bleeding management, has received 510(k)...
ANN ARBOR, Mich., September 25, 2025 — Cayman Chemical, a global provider of life science research tools, and Akadeum...
STAMFORD, CT, September 25, 2025 — Apiject Systems, Corp., a leading medical technology innovator, submitted its New Drug Application...
SAN DIEGO, Sept. 25, 2025 — ClearNote Health announced that it has received UK Conformity Assessed (UKCA) approval for...
ANN ARBOR, Mich., September 23, 2025 – Micromedex has launched an AI-powered search capability to provide clinicians with faster,...
SEOUL, South Korea — September 22, 2025 — Lunit and Agilent Technologies have launched a non-exclusive collaboration to co-develop...
CANTON, Conn., September 18, 2025 – Kelyniam Global, Inc., a leader in custom cranial and craniofacial implant solutions, announced...
September 18, 2025 — Caesarea, Israel IceCure has been granted a Notice of Allowance by the U.S. Patent and...
September 18, 2025 — Cambridge, Massachusetts Biogen has announced the acquisition of Alcyone Therapeutics, a Massachusetts-based biotech company specializing...
September 17, 2025 — The Hague, The Netherlands Amber Implants has received FDA 510(k) clearance for its VCFix® Spinal...
